Inovio Pharmaceuticals (GBM.F) Q4 2024 Earnings

14NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.21
-1.09
-0.97
-0.85

Details

Expected EPS
-1.0921089999999998
Actual EPS
-0.8451974
Surprise EPS
0.25
Surprise Percent
+22.61%

Description

Inovio Pharmaceuticals (GBM.F) has reported earnings of -0.8451974 per share for Q4 2024.

0 Comments

Share your thoughts